MedPage Today on MSN
New FDA-Approved Option for HER2-Mutated Lung Cancer
The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...
"In the middle of all the scans I thought... I'm fit and healthy... people like me don't get lung cancer, so to say it was a ...
“The biggest risk for lung cancer is cigarette smoking,” says Waqar. It’s estimated that 85% of lung cancer deaths are ...
When Donna Rigby mentioned feeling winded walking from her car, her physician's decision to order a scan revealed early-stage ...
Humphrey traveled from Michigan to Chicago to seek a second opinion at Northwestern Medicine in May 2024. A bronchoscopy ...
Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...
Each year, about 209,000 Americans are told they have lung cancer, and about 132,000 people die from the disease, according ...
MONTGOMERY, Ala. ( WSFA) - November is Lung Cancer Awareness Month putting a national spotlight on early detection and better ...
13h
If you experience these symptoms repeatedly, you could have lung cancer: “You should see a doctor”
A health campaign urges the public to pay closer attention to subtle warning signs that often go unnoticed in the earliest ...
The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...
Approximately 20% of new lung cancer diagnoses occur in nonsmokers in the U.S., according to The Ohio State University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback